Workflow
Yongmaotai(605208)
icon
Search documents
永茂泰(605208) - 2024年年度权益分派实施公告
2025-06-27 10:00
上海永茂泰汽车科技股份有限公司 2024年年度权益分派实施公告 证券代码:605208 证券简称:永茂泰 公告编号:2025-040 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗 漏,并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示: 每股分配比例 A 股每股现金红利0.039元 相关日期 | 股份类别 | 股权登记日 | 最后交易日 | 除权(息)日 | 现金红利发放日 | | --- | --- | --- | --- | --- | | A股 | 2025/7/3 | - | 2025/7/4 | 2025/7/4 | 差异化分红送转: 是 一、通过分配方案的股东大会届次和日期 本次利润分配方案经公司2025 年 5 月 16 日的2024年年度股东大会审议通过。 二、分配方案 1. 发放年度:2024年年度 2. 分派对象: 截至股权登记日下午上海证券交易所收市后,在中国证券登记结算有限责任公司上海分 公司(以下简称"中国结算上海分公司")登记在册的、除公司回购专用证券账户以外的本公 司股东。根据《上海证券交易所上市公司自律监管指引第 7 号—回购股份》等 ...
永茂泰(605208) - 关于全资子公司担保进展公告
2025-06-10 16:31
本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏,并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示: 被担保人:全资子公司上海永茂泰汽车零部件有限公司 本次担保金额:人民币 12,000 万元;截至 2025 年 6 月 9 日,对上海零 部件的担保余额(担保项下实际取得融资额)为 44,400 万元。 一、担保情况概述 (一)担保情况 近日,上海永茂泰汽车科技股份有限公司(以下简称"公司")与南京银行 上海分行(以下简称"银行")签订《最高额保证合同》,为全资子公司上海永 茂泰汽车零部件有限公司(以下简称"上海零部件")在银行办理具体授信业务 所形成的银行债权提供连带责任保证担保,担保的债权最高本金余额为 12,000 万元,担保期限为主合同项下债务人每次使用授信额度而发生的债务履行期限 届满之日起三年。本次担保不存在反担保。 证券代码:605208 证券简称:永茂泰 公告编号:2025-039 上海永茂泰汽车科技股份有限公司 关于全资子公司担保进展公告 (二)本次担保履行的内部决策程序 公司于 2025 年 4 月 17 日召开第三届董事会第十三次会议,审议通 ...
永茂泰(605208) - 关于全资子公司担保进展公告
2025-06-10 10:31
证券代码:605208 证券简称:永茂泰 公告编号:2025-039 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏,并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示: 被担保人:全资子公司上海永茂泰汽车零部件有限公司 本次担保金额:人民币 12,000 万元;截至 2025 年 6 月 9 日,对上海零 部件的担保余额(担保项下实际取得融资额)为 44,400 万元。 一、担保情况概述 (一)担保情况 近日,上海永茂泰汽车科技股份有限公司(以下简称"公司")与南京银行 上海分行(以下简称"银行")签订《最高额保证合同》,为全资子公司上海永 茂泰汽车零部件有限公司(以下简称"上海零部件")在银行办理具体授信业务 所形成的银行债权提供连带责任保证担保,担保的债权最高本金余额为 12,000 万元,担保期限为主合同项下债务人每次使用授信额度而发生的债务履行期限 届满之日起三年。本次担保不存在反担保。 (二)本次担保履行的内部决策程序 上海永茂泰汽车科技股份有限公司 关于全资子公司担保进展公告 自 2025 年 5 月 20 日起至 2026 年 5 月 19 日止( ...
永茂泰实控人方拟减持 2021年上市募资6.3亿元
Zhong Guo Jing Ji Wang· 2025-05-27 06:57
| 股东名称 | 上海磊昶投资合伙企业(有限合伙) | | | --- | --- | --- | | 股东身份 | 控股股东、实控人及一致行动人 | √是 □否 | | | 直接持股 5%以上股东 | □是 √否 | | | 董事、监事和高级管理人员 | □是 √否 | | | 其他:无 | | | 持股数量 | 13.969.800股 | | | 持股比例 | 4. 23% | | | 当前持股股份来源 | IP0 前取得: 13,969,800股 | | | 股东名称 | 上海宏芝投资合伙企业(有限合伙) | | | --- | --- | --- | | 股东身份 | 控股股东、实控人及一致行动人 | √是 □否 | | | 直接持股 5%以上股东 | □是 √否 | | | 董事、监事和高级管理人员 | □是 √否 | | | 其他:无 | | | 持股数量 | 3.580.200股 | | | 持股比例 | 1. 09% | | | 当前持股股份来源 | IP0 前取得: 3,580,200股 | | | | 股东名称 | 持股数量 | 持股比例 | 一致行动关系形成原因 | | --- | -- ...
上海永茂泰汽车科技股份有限公司股东减持股份计划公告
Core Viewpoint - Shanghai Yongmaotai Automotive Technology Co., Ltd. announced a share reduction plan by its shareholders, which includes specific details on the number of shares to be sold and the methods of sale [2][3][4]. Summary by Relevant Sections Shareholder Reduction Plan - The reduction subjects are Shanghai Leichang Investment Partnership and Shanghai Hongzhi Investment Partnership, holding 4.23% and 1.09% of the total shares respectively, all acquired before the IPO [2]. - Leichang Investment plans to reduce up to 6,984,800 shares (approximately 2.117% of total shares) through centralized bidding and block trading, while Hongzhi Investment plans to reduce up to 1,790,100 shares (approximately 0.543%) [2]. Shareholder Background - Both reduction subjects were established in January 2016 as employee stock ownership platforms and have not previously reduced their holdings [2]. Previous Commitments - The shareholders made commitments during the IPO to not transfer their shares for 36 months post-listing, with specific conditions for extending the lock-up period if certain price conditions were met [3][4]. - After the lock-up period, they can reduce their holdings under certain conditions, including notifying the company three trading days in advance [4]. Compliance and Disclosure - The company will ensure that the reduction subjects comply with relevant laws and regulations during the reduction process and will fulfill its information disclosure obligations [5].
公告精选丨隆基绿能:李振国辞去总经理及法定代表人职务;平治信息:签订2.46亿元AI算力技术服务框架协议
Group 1: Company Leadership Changes - Longi Green Energy announced that Li Zhenguo will resign from the positions of General Manager and Legal Representative to focus on R&D and technology management, while continuing as the head of the Central Research Institute and Chief Technology Officer [2] - The company appointed Zhong Baoshan as the new General Manager, and this leadership change is not expected to impact the company's operations [2] Group 2: Contracts and Agreements - Pingzhi Information signed an AI computing power technology service framework agreement with China Telecom's Shaanxi branch, with a total contract value of approximately 246 million yuan [3] - The actual execution amount will depend on specific orders, and the agreement is not expected to have a significant impact on the company's annual performance [3] Group 3: Share Issuance and Stock Transactions - *ST Songfa announced the issuance of 738 million new shares at a price of 10.16 yuan per share for asset acquisition [5] - Shenghong Technology set the preliminary inquiry transfer price at 65.85 yuan per share, with 24 institutional investors participating in the inquiry [3] Group 4: Shareholder Actions - Xinhua Medical's controlling shareholder plans to increase holdings by 100 million to 200 million yuan [6] - Several companies, including Yongmaotai and Green Harmony, announced plans for share reductions by up to 3% of total shares [6] Group 5: Corporate Developments - Rongsheng Environmental Protection reported that its controlling shareholder, Feng Ronghua, has been taken into custody by law enforcement, but this matter is unrelated to the company [4] - Chongqing Steel terminated the absorption merger with its wholly-owned subsidiary [7]
5月26日晚间重要公告一览
Xi Niu Cai Jing· 2025-05-26 10:11
Group 1 - Company Sun Energy plans to repurchase shares worth between 100 million to 200 million yuan for cancellation, with a maximum repurchase price of 6.69 yuan per share [1] - Company Runyang Technology intends to invest up to 300 million yuan in Shanghai Fourier Intelligent Technology Co., with a pre-investment valuation of 8 billion yuan [1] - Company Heng Rui Medicine's subsidiary has received approval for clinical trials of SHR-4712 injection for treating advanced solid tumors [2] Group 2 - Company Lianhuan Pharmaceutical plans to increase capital by 60 million yuan for its wholly-owned subsidiary [2] - Company Hongchang Electronics' subsidiary plans to increase capital by 10 million USD for its other subsidiary [2] - Company Sichuan Meifeng intends to repurchase shares worth between 50 million to 70 million yuan for cancellation, with a maximum repurchase price of 10.07 yuan per share [2] Group 3 - Company Lian Micro plans to liquidate and deregister Jiaxing Kangjing Semiconductor Industry Investment Partnership [4] - Company Jiutian Pharmaceutical has received approval for clinical trials of PDX-04 drug for treating acute gout attacks [5] - Company Pingzhi Information has signed a framework agreement with China Telecom for a GPU computing power project worth approximately 246 million yuan [7] Group 4 - Company Jiu Zhi Tang's subsidiary has initiated Phase II clinical trials for new drug YB211 aimed at treating acute bacterial skin infections [8] - Company Fosun Pharma's subsidiary has received orphan drug designation for HLX22 for gastric cancer treatment in the EU [9] - Company Jianyou Co. plans to repurchase shares worth between 20 million to 40 million yuan for employee stock ownership plans [11] Group 5 - Company Zhi Zheng Co. announced the resignation of its vice president due to personal reasons [13] - Company He Mai Co. signed a cooperation agreement for household photovoltaic systems worth 1 billion yuan [14] - Company Jinan Intelligent's subsidiary won a project bid for electric vehicle charging stations, expected to positively impact performance [16] Group 6 - Company Gaotie Electric plans to distribute a cash dividend of 0.012 yuan per share [18] - Company Guyue Longshan plans to distribute a cash dividend of 0.08 yuan per share [18] - Company Yongmaotai's shareholders plan to reduce their holdings by up to 2.66% of the company's shares [19] Group 7 - Company Tian Cheng Technology's subsidiary received a land idle fee notice for 2.1658 million yuan due to project delays [20] - Company Guangri Co. appointed a new vice president and board secretary to enhance governance [21] - Company Design General Institute won multiple major projects totaling approximately 390 million yuan [22] Group 8 - Company Fuxie Environmental signed a significant contract worth 244 million yuan for a sewage treatment project [23] - Company Lujiazui announced the resignation of its vice chairman due to job transfer [24] - Company Three Squirrels' H-share issuance application has been accepted by the CSRC [24] Group 9 - Company Kanghong Pharmaceutical's subsidiary received approval for clinical trials of KH617 for glioblastoma treatment [25] - Company Xin Zhu Co. announced a suspension of trading to plan an asset acquisition from its controlling shareholder [26] - Company Jianxin Co. announced plans for share reductions by several directors and senior management [28]
永茂泰: 股东减持股份计划公告
Zheng Quan Zhi Xing· 2025-05-26 09:30
以集中竞价交易方式减持不超过 673,100 股、以大宗交易方式减持不超过 1,117,000 股,合计不超过 1,790,100 股,约占公司总股本的 0.543% 证券代码:605208 证券简称:永茂泰 公告编号:2025-038 上海永茂泰汽车科技股份有限公司 (以下简称"宏芝投资"), 本公司董事会、全体董事及相关股东保证本公告内容不存在任何虚假记载、误导 性陈述或者重大遗漏,并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示: ? 减持主体持股的基本情况:本次减持主体为上海磊昶投资合伙企业(有限合伙) 其中磊昶投资持有公司 13,969,800 股,占公司总股本的 4.23%;宏芝投资持有公司 ? 减持计划的主要内容:自本公告披露之日起 15 个交易日后的 3 个月内,磊昶投资拟 (以 以 集 中竞 价 交 易 方 式 减 持 不超 过 2,626,300 股 、 以 大 宗 交 易 方 式 减 持 不 超 过 下简称"磊昶投资")、上海宏芝投资合伙企业(有限合伙) (二)减持计划实施是否可能导致上市公司控制权发生变更的风险 □是 √否 (三)公司将督促本次减持主体在上述减持计划实施期 ...
永茂泰(605208) - 股东减持股份计划公告
2025-05-26 08:45
证券代码:605208 证券简称:永茂泰 公告编号:2025-038 上海永茂泰汽车科技股份有限公司 股东减持股份计划公告 | 股东名称 | 上海磊昶投资合伙企业(有限合伙) | | --- | --- | | 计划减持数量 | 不超过:6,984,800 股 | | 计划减持比例 | 不超过:2.117% | | 减持方式及对应减持数量 | 集中竞价减持,不超过:2,626,300 股 大宗交易减持,不超过:4,358,500 股 | | 减持期间 | 2025 年 6 月 18 日~2025 年 9 月 17 日 | | 拟减持股份来源 | IPO 前取得 | | 拟减持原因 | 自身资金需求 | 本公司董事会、全体董事及相关股东保证本公告内容不存在任何虚假记载、误导 性陈述或者重大遗漏,并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示: 一、减持主体的基本情况 | 股东名称 | 上海磊昶投资合伙企业(有限合伙) | | | | --- | --- | --- | --- | | 股东身份 | 控股股东、实控人及一致行动人 | √是 | □否 | | | 直接持股 5%以上股东 | □是 | ...
永茂泰:股东磊昶投资和宏芝投资拟分别减持2.117%和0.543%公司股份
news flash· 2025-05-26 08:19
Group 1 - The core point of the announcement is that shareholders of Yongmoutai (605208) plan to reduce their holdings, with Leichang Investment intending to sell up to 6.9848 million shares, accounting for approximately 2.117% of the company's total share capital [1] - Hongzhi Investment plans to reduce its holdings by up to 1.7901 million shares, which represents about 0.543% of the company's total share capital [1] - The reduction will be executed through centralized bidding and block trading, with the selling period set from June 18, 2025, to September 17, 2025 [1]